| Mutations in the activin receptor–like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2 DW Johnson, JN Berg, MA Baldwin, CJ Gallione, I Marondel, SJ Yoon, ... Nature genetics 13 (2), 189-195, 1996 | 1314 | 1996 |
| Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia RC Trembath, JR Thomson, RD Machado, NV Morgan, C Atkinson, ... New England Journal of Medicine 345 (5), 325-334, 2001 | 899 | 2001 |
| Prevalence and architecture of de novo mutations in developmental disorders Nature 542 (7642), 433-438, 2017 | 878 | 2017 |
| Large-scale discovery of novel genetic causes of developmental disorders Nature 519 (7542), 223-228, 2015 | 742 | 2015 |
| Germline mutations in RAD51D confer susceptibility to ovarian cancer C Loveday, C Turnbull, E Ramsay, D Hughes, E Ruark, JR Frankum, ... Nature genetics 43 (9), 879-882, 2011 | 603 | 2011 |
| The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2 JN Berg, CJ Gallione, TT Stenzel, DW Johnson, WP Allen, CE Schwartz, ... The American Journal of Human Genetics 61 (1), 60-67, 1997 | 287 | 1997 |
| Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer E Ruark, K Snape, P Humburg, C Loveday, I Bajrami, R Brough, ... Nature 493 (7432), 406-410, 2013 | 272 | 2013 |
| Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations J Berg, M Porteous, D Reinhardt, C Gallione, S Holloway, T Umasunthar, ... Journal of medical genetics 40 (8), 585-590, 2003 | 227 | 2003 |
| A second locus for hereditary hemorrhagic telangiectasia maps to chromosome 12. DW Johnson, JN Berg, CJ Gallione, KA McAllister, JP Warner, ... Genome Research 5 (1), 21-28, 1995 | 216 | 1995 |
| Histone lysine methylases and demethylases in the landscape of human developmental disorders V Faundes, WG Newman, L Bernardini, N Canham, J Clayton-Smith, ... The American Journal of Human Genetics 102 (1), 175-187, 2018 | 205 | 2018 |
| Germline FH Mutations Presenting With Pheochromocytoma GR Clark, M Sciacovelli, E Gaude, DM Walsh, G Kirby, MA Simpson, ... The Journal of Clinical Endocrinology & Metabolism 99 (10), E2046-E2050, 2014 | 180 | 2014 |
| Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects V Wouters, N Limaye, M Uebelhoer, A Irrthum, LM Boon, JB Mulliken, ... European Journal of Human Genetics 18 (4), 414-420, 2010 | 174 | 2010 |
| Clinical heterogeneity in hereditary haemorrhagic telangiectasia: are pulmonary arteriovenous malformations more common in families linked to endoglin? JN Berg, AE Guttmacher, DA Marchuk, ME Porteous Journal of medical genetics 33 (3), 256-257, 1996 | 166 | 1996 |
| Allelic and locus heterogeneity in inherited venous malformations JT Calvert, TJ Riney, CD Kontos, EH Cha, VG Prieto, CR Shea, JN Berg, ... Human molecular genetics 8 (7), 1279-1289, 1999 | 157 | 1999 |
| De novo mutations in protein kinase genes CAMK2A and CAMK2B cause intellectual disability S Küry, GM van Woerden, T Besnard, MP Onori, X Latypova, MC Towne, ... The American Journal of Human Genetics 101 (5), 768-788, 2017 | 144 | 2017 |
| Six novel mutations in the endoglin gene in hereditary hemorrhagic telangiectasia type 1 suggest a dominant-negative effect of receptor function KA McAllister, MA Baldwin, AK Thukkani, CJ Gallione, JN Berg, ... Human Molecular Genetics 4 (10), 1983-1985, 1995 | 134 | 1995 |
| Methylation analysis and diagnostics of Beckwith-Wiedemann syndrome in 1,000 subjects A Ibrahim, G Kirby, C Hardy, RP Dias, L Tee, D Lim, J Berg, F MacDonald, ... Clinical epigenetics 6, 1-10, 2014 | 119 | 2014 |
| Functionally distinct groups of inherited PTEN mutations in autism and tumour syndromes L Spinelli, FM Black, JN Berg, BJ Eickholt, NR Leslie Journal of Medical Genetics 52 (2), 128-134, 2015 | 116 | 2015 |
| Mutation and expression analysis of the endoglin gene in hereditary hemorrhagic telangiectasia reveals null alleles CJ Gallione, DJ Klaus, EY Yeh, TT Stenzel, Y Xue, KB Anthony, ... Human mutation 11 (4), 286-294, 1998 | 114 | 1998 |
| Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial M Mullen, XY Jin, A Child, AG Stuart, M Dodd, JA Aragon-Martin, D Gaze, ... The Lancet 394 (10216), 2263-2270, 2019 | 112 | 2019 |
